| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 701.69B | 702.08B | 680.09B | 662.20B | 602.70B | 572.76B |
| Gross Profit | 126.73B | 126.23B | 120.15B | 108.87B | 102.25B | 98.80B |
| EBITDA | 61.22B | 63.30B | 61.73B | 55.63B | 52.78B | 52.87B |
| Net Income | 23.93B | 24.73B | 24.50B | 21.57B | 23.38B | 21.21B |
Balance Sheet | ||||||
| Total Assets | 502.60B | 504.46B | 489.72B | 461.36B | 431.77B | 410.17B |
| Cash, Cash Equivalents and Short-Term Investments | 39.17B | 39.37B | 31.28B | 27.84B | 23.41B | 28.93B |
| Total Debt | 111.75B | 106.25B | 97.95B | 114.58B | 104.71B | 96.42B |
| Total Liabilities | 230.01B | 228.49B | 223.77B | 227.84B | 213.87B | 199.73B |
| Stockholders Equity | 256.85B | 260.04B | 253.41B | 224.44B | 211.17B | 203.33B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 24.87B | 35.72B | 14.04B | 13.37B | 16.92B |
| Operating Cash Flow | 0.00 | 53.19B | 62.44B | 37.87B | 34.66B | 45.45B |
| Investing Cash Flow | 0.00 | -32.40B | -31.41B | -26.84B | -26.02B | -32.21B |
| Financing Cash Flow | 0.00 | -16.80B | -31.43B | -8.59B | -14.18B | -10.71B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥657.17B | 14.65 | 9.18% | 1.13% | 5.55% | 17.29% | |
73 Outperform | ¥375.82B | 10.77 | 10.18% | 2.56% | 4.98% | 23.38% | |
72 Outperform | ¥479.36B | 15.17 | 9.86% | 2.58% | 0.63% | 5.96% | |
66 Neutral | ¥830.40B | 12.71 | 9.77% | 2.41% | 1.90% | 7.42% | |
63 Neutral | ¥610.55B | 15.19 | 6.04% | 2.04% | 4.68% | 16.45% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
61 Neutral | ¥4.57T | 20.92 | 9.46% | 1.32% | 1.38% | -12.32% |